By South Asia Monitor/JEN | @justearthnews | 16 Jun 2021, 08:29 am Print

Image: Wikimedia Commons
Bangladesh has approved Johnson and Johnson’s single-dose Covid-19 for emergency use in the country, making it the sixth vaccine to get approval. The country is all set to resume its national vaccination campaign on Saturday.
On Tuesday, the country’s Directorate-General of Drug Administration (DGDA) has granted emergency use approval to the vaccine after scrutinized all document and clinal trial data submitted by the manufacturer, reported Dhaka Tribune.
So far, it has approved six vaccines for usage in the country: AstraZeneca-Oxford vaccine, Sputnik-V, Pfizer, Sinopharm, and Sinovac. However, Astra-Zeneca and Sinopharm are the two main vaccines used for the national vaccination drive.
The supply of the Astra-Zeneca/Covishield vaccine was disrupted in April this year following the disastrous Covid-19 surge in India, prompting the Indian government to halt the export.
- Ebola vaccination trial begins in Uganda following recent outbreak
- WHO confirms Ebola outbreak in Uganda
- WHO declares Georgia as malaria free
- Medical experts propose new definitions of obesity which is not only about BMI
- Avian flu risk still remains 'low' despite US registering first death due to H5N1 virus, says WHO